Mutation Characteristics of inhA and katG Genes in Isoniazid-Resistant Mycobacterium Tuberculosis Patients in Xinjiang
Download PDF

Keywords

Mycobacterium tuberculosis
Drug resistance
Isoniazid
Gene mutation

DOI

10.26689/jcnr.v8i1.5893

Submitted : 2023-12-30
Accepted : 2024-01-14
Published : 2024-01-29

Abstract

Objective: To analyze the mutation characteristics of inhA and katG genes in isoniazid-resistant Mycobacterium tuberculosis in Xinjiang. Methods: The katG and inhA in 148 strains of isoniazid-resistant Mycobacterium tuberculosis were amplified through fluorescence quantitative PCR, and the amplified products were sequenced and compared. Results:The inhA gene mutation rate of 148 strains of isoniazid-resistant mycobacterium tuberculosis was 13.51% (20/148), among which the inhA gene mutation rate among patients of Han, Uygur, and Kazakh ethnicity were 15.87%, 13.21%, and 17.65%, respectively. There was no significant difference in the inhA mutation rate among ethnic groups (c2 = 2.897, P > 0.05). The mutation rate of the katG gene was 84.46% (125/148), among which the mutation rates of patients of Han, Uyghur, and Kazak ethnicities were 82.54%, 84.91%, and 76.47%, respectively. The Hui and other ethnic groups were all affected by the katG gene mutation. There was no significant difference in the mutation rate of the katG gene among different ethnicities (c2 = 3.772, P > 0.05). The mutation rates of the inhA gene in southern Xinjiang, northern Xinjiang, and other provinces were 18.60%, 9.28%, and 37.50%, respectively. The mutation rates of the inhA gene in different regions were statistically different (c2 = 6.381, P < 0.05). There was no significant difference in the inhA mutation rate between patients from southern and northern Xinjiang (c2 = 2.214, P > 0.05) and between southern Xinjiang and other provinces (c2 =1.424, P > 0.05). However, the mutation rate of the inhA gene in patients from other provinces was higher than that in northern Xinjiang (c2 = 5.539, P < 0.05). The mutation rates of the katG gene in southern Xinjiang, northern Xinjiang, and other provinces were 81.40%, 87.63%, and 62.50%, respectively. There was no significant difference in the mutation rates of the katG gene among different regions (c2 = 3.989, P > 0.05). Conclusion: katG gene mutation was predominant in isoniazid-resistant tuberculosis patients in Xinjiang Uygur Autonomous Region, and inhA and katG gene mutation were no different among different ethnic groups.

References

World Health Organization, Global Tuberculosis Report 2021, viewed October 26, 2023, Decemhttps://www.who.int/publications/digital/global-tuberculosis-report-2021

World Health Organization, 2020, Global Tuberculosis Report 2020, viewed October 26, 2023, https://www.who.int/tb/publications/global report/en/

Liu J, Zhong Q, 2020, Challenges and Response Strategies for “Ending Tuberculosis”. Chinese Journal of Anti-Tuberculosis, 42(04): 308–310.

Fu L, Gao J, Deng G, et al., 2018, WHO Treatment Guidelines for Isoniazid-Resistant Tuberculosis: Supplement to the WHO Treatment Guidelines for Drug-Resistant Tuberculosis. International Respiratory Journal, 38(24): 1841–1845.

Chen S, Liu H, Dan W, et al., 2016, Advances in Correlation Between Drug Resistance Phenotype and Genotype of Mycobacterium Tuberculosis. Chinese Journal of Infection Control, 15(11): 883–886.

Song Y, Wang G, Huo F, et al., 2018, Correlation Analysis Between inhA Gene Mutations and Resistance to Prothionamide in Multidrug-Resistant and Extensively Drug-Resistant MTB. Chinese Journal of Anti-Tuberculosis, 40(8): 821–824.

Tian L, Zhou W, Huang X, et al. 2022, Analysis of Gene Mutation Characteristics of Isoniazid-Resistant Mycobacterium Tuberculosis in China. Chinese Journal of Antituberculosis, 44(04): 354–361.

Miotto P, Zhang Y, Maria D, et al., 2018, Drug Resistance Mechanisms and Drug Susceptibility Testing for Tuberculosis. Respirology, 23(12): 1098–1113.

Zhao LL, Chen Y, Chen ZN, et al., 2014, Prevalence and Molecular Characteristics of Drug-Resistant Mycobacterium Tuberculosis in Hunan, China. Antimicrobial Agents and Chemotherapy, 58(6): 3475–3480.

Victor TC, van Helden PD, Warren R, 2002, Prediction of Drug Resistance in M. Tuberculosis: Molecular Mechanisms, Tools, and Applications. IUBMB Life, 53(4): 231–237.

Zhu D, Liu W, Shen J, et al., 2022, Research on Isoniazid and Prothionamide Resistance and Cross-Resistance-Related Gene Mutations of Mycobacterium Tuberculosis in Chongqing. Chinese Journal of Zoonosis, 38(05): 405–409.

Chen L, 2022, Analysis of Resistance Levels and Mutation Frequency Characteristics of katG, inhA and rpoB Gene Mutation Sites of Mycobacterium Tuberculosis in Sichuan. Journal of Clinical Pulmonology, 27(02): 242–246.

Chen L, Ru H, Yang X, et al., 2022, Characteristics of katG and inhA Gene Mutations in isoniazid-Resistant Mycobacterium Tuberculosis in Yunnan Province. Journal of Kunming Medical University, 43(08): 28–33.

Dong L, Qiang C, Xiong G, et al., 2019, Prevalence and Molecular Characterization of Multidrug-Resistant M. Tuberculosis in Jiangxi Province, China. Scientific Reports, 9(1): 7315.

Zhang W, Yang X, Zhang Li, et al., 2017, Analysis of rpoB and katG Gene Mutation Characteristics of Multidrug-Resistant Mycobacterium Tuberculosis in Jilin Province. Chinese Experimental Diagnostics, 21(10): 1731–1735.

Wen S, Lin Z, Liu D, et al., 2019, Isoniazid-Resistant Mycobacterium Tuberculosis and Mutations in its katG and inhA Genes. Chinese Thermal Medicine, 19(08): 723–726.

Jia H, Xu Y, Sun Z, 2021, Analysis on Drug-Resistance-Associated Mutations Among Multidrug-Resist-Ant Mycobacterium Tuberculosis Isolates in China. Antibiotics, 10(11): 1367–1377.